Insights On Enterprise Solutions

  1. Validation Provider Shortens The Path To Equipment Qualification 8/19/2025

    Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.

  2. Future-Proofing A Volatile Supply Chain Through Modular Biomanufacturing 8/16/2025

    Biopharmaceutical supply chain volatility is at an all-time high. To navigate this complexity, CDMOs must prioritize robust sourcing strategies and proactive vendor management.

  3. Keys To Achieving Unparalleled Flexibility In CHO Based Bioproduction 8/16/2025

    The dynamic growth and pace of change observed in novel mAb formats and cell and gene therapies emphasizes that biomanufacturing innovation is essential to deliver scale, speed, and sustainability.

  4. Strategies To Enhance Efficiency In mAb Bioprocess Development 8/16/2025

    Advanced computational methods coupled with bioinformatics can be used to navigate the complexities of bioprocessing by anticipating challenges before they arise.

  5. Building A Biomanufacturing Ecosystem For Supply Agility Starts Early 8/16/2025

    Unprecedented capital investments of >$8bn expand capacity to improve patient access. Going beyond expansions, learn more about a holistic, globally harmonized operational ecosystem.

  6. A Paradigm Shift From Glass Benchtop Bioreactors 8/14/2025

    Learn how a bench-scale single-use bioreactor offers process development advantages over traditional glass systems, including higher efficiency, increased productivity, and enhanced sustainability.

  7. Scalability From 5L To 50L Using The DynaDrive Single-Use Bioreactor 8/14/2025

    Maintaining a consistent bioprocess when scaling from 5 L to 50 L is achievable. This study shows how to successfully scale processes while maintaining cell density, viability, and protein production.

  8. A Guide To Analytical Characterization Of Complex Molecular Formats 8/12/2025

    A thorough and adaptable analytical strategy is essential for navigating the complex mAb market. This approach boosts the likelihood of market approval and unlocks the full potential of these therapies.

  9. Efficient Scale-Up Of Monoclonal Antibody Production: From Bench Top To 500L 8/11/2025

    Scaling monoclonal antibody production from the lab to a commercial scale can be challenging. Learn about an approach that helps you maintain consistent productivity and product quality across all scales.

  10. The Compliance Risks Of Disconnected Automation Systems 8/11/2025

    Isolated automation systems fragment critical data and slow key processes, introducing compliance risks and costly delays. Learn how an integrated approach can build a more cohesive, compliant, and efficient automation landscape.